Literature DB >> 30237218

Metabolic Acidosis and Cardiovascular Disease Risk in CKD.

Matthew K Abramowitz1.   

Abstract

Entities:  

Keywords:  Acid-Base Equilibrium; Renal Insufficiency, Chronic; acidosis; cardiovascular disease; chronic kidney disease; chronic metabolic acidosis

Mesh：

Year:  2018        PMID： 30237218      PMCID： PMC6218834          DOI： 10.2215/CJN.10120818

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.

Authors:  Jessica Kendrick; Pratik Shah; Emily Andrews; Zhiying You; Kristen Nowak; Andreas Pasch; Michel Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-20       Impact factor: 8.237

2.  Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.

Authors:  Mirela Dobre; Jason Roy; Kaixiang Tao; Amanda H Anderson; Nisha Bansal; Jing Chen; Rajat Deo; Paul Drawz; Harold I Feldman; L Lee Hamm; Thomas Hostetter; John W Kusek; Claudia Lora; Akinlolu O Ojo; Kumar Shrama; Mahboob Rahman
Journal:  Am J Nephrol       Date:  2016-05-28       Impact factor: 3.754

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

4.  Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.

Authors:  Avinash Kumar Dubey; Jayaprakash Sahoo; Balasubramanian Vairappan; Satish Haridasan; Sreejith Parameswaran; P S Priyamvada
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992

5.  Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

Authors:  Jenny E Blau; Viviana Bauman; Ellen M Conway; Paolo Piaggi; Mary F Walter; Elizabeth C Wright; Shanna Bernstein; Amber B Courville; Michael T Collins; Kristina I Rother; Simeon I Taylor
Journal:  JCI Insight       Date:  2018-04-19

6.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

7.  Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Jessica B Kendrick; Leila Zelnick; Michel B Chonchol; David Siscovick; Andrew N Hoofnagle; Joachim H Ix; Mark Sarnak; Michael G Shlipak; Bryan Kestenbaum; Ian H de Boer
Journal:  Am J Nephrol       Date:  2016-12-10       Impact factor: 3.754

8.  Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Authors:  Mirela Dobre; Wei Yang; Jing Chen; Paul Drawz; L Lee Hamm; Edward Horwitz; Thomas Hostetter; Bernard Jaar; Claudia M Lora; Lisa Nessel; Akinlolu Ojo; Julia Scialla; Susan Steigerwalt; Valerie Teal; Myles Wolf; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2013-03-13       Impact factor: 8.860

9.  Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  S A Paul Chubb; Wendy A Davis; Kirsten E Peters; Timothy M E Davis
Journal:  Cardiovasc Diabetol       Date:  2016-10-06       Impact factor: 9.951

10.  Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.

Authors:  Wei Chen; Michal L Melamed; Thomas H Hostetter; Carolyn Bauer; Amanda C Raff; Anthony L Almudevar; Amy Lalonde; Susan Messing; Matthew K Abramowitz
Journal:  BMC Nephrol       Date:  2016-08-05       Impact factor: 2.388
View more
  3 in total

1.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 2.  The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fang Cheng; Qiang Li; Jinglin Wang; Zhendi Wang; Fang Zeng; Yu Zhang
Journal:  Ther Clin Risk Manag       Date:  2021-12-07       Impact factor: 2.423

3.  Bicarbonate Therapy in Renally Compromised Critically Ill Patients with Metabolic Acidosis: Study of Clinical Outcomes and Mortality Rate.

Authors:  Zakia Rafique; Muhammad Haseeb Tariq; Arif-Ullah Khan; Muhammad Junaid Farrukh; Nida Khan; Ahmed Mujadid Burki; Khalid Mehmood
Journal:  Int J Gen Med       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.